Stem (NYSE:STEM – Get Free Report) had its price target lowered by research analysts at BMO Capital Markets from $0.50 to $0.40 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has a “market perform” rating on the stock. BMO Capital Markets’ target price would indicate a potential downside of 12.47% from the stock’s previous close.
A number of other research analysts have also commented on the stock. UBS Group dropped their price objective on shares of Stem from $1.00 to $0.60 and set a “buy” rating on the stock in a research note on Friday, November 8th. Piper Sandler decreased their price objective on Stem from $1.50 to $0.30 and set a “neutral” rating for the company in a research report on Friday, November 22nd. Six equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $1.19.
Read Our Latest Stock Analysis on STEM
Stem Price Performance
Stem (NYSE:STEM – Get Free Report) last issued its quarterly earnings data on Tuesday, March 4th. The company reported ($0.12) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.04. The company had revenue of $55.83 million during the quarter, compared to analysts’ expectations of $47.89 million. Stem had a negative return on equity of 275.79% and a negative net margin of 328.11%. During the same quarter in the previous year, the business earned ($0.21) earnings per share. Sell-side analysts expect that Stem will post -0.52 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the business. Barclays PLC boosted its position in shares of Stem by 213.1% during the 3rd quarter. Barclays PLC now owns 235,336 shares of the company’s stock worth $81,000 after purchasing an additional 160,165 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Stem by 4.8% in the third quarter. Geode Capital Management LLC now owns 3,604,073 shares of the company’s stock valued at $1,255,000 after purchasing an additional 166,002 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Stem by 77.1% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,406,080 shares of the company’s stock worth $837,000 after buying an additional 1,047,825 shares in the last quarter. Creative Planning grew its position in Stem by 177.1% during the third quarter. Creative Planning now owns 123,521 shares of the company’s stock worth $43,000 after buying an additional 78,940 shares during the period. Finally, Aries Wealth Management increased its holdings in Stem by 100.0% in the fourth quarter. Aries Wealth Management now owns 50,000 shares of the company’s stock valued at $30,000 after buying an additional 25,000 shares in the last quarter. Institutional investors and hedge funds own 61.63% of the company’s stock.
Stem Company Profile
Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.
Read More
- Five stocks we like better than Stem
- Using the MarketBeat Stock Split Calculator
- Is Advanced Micro Devices Stock Slide Over?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Lemonade’s Q4 Surge: Has This AI-Powered Insurer Turned a Corner?
- 3 Warren Buffett Stocks to Buy Now
- 2 Energy Stocks to Play Both Sides of Tariff Uncertainty
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.